Univariate analysis | Mutivariate analysis | |||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
Age (≧75vs < 75) | 3.200 | 1.377–7.437 | 0.007 | 1.754 | 0.670–4.594 | 0.252 |
Gender (Female vs Male) | 0.728 | 0.268–1.978 | 0.534 | |||
mFI (≧0.91 vs < 0.91) | 1.296 | 0.573–2.930 | 0.534 | |||
CCI (Moderate/severe vs Low) | 1.017 | 0.453–2.282 | 0.967 | |||
Lymphatic invasion (3 vs 0,1,2) | 3.608 | 1.584–8.214 | 0.002 | 4.356 | 1.695–11.196 | 0.002 |
Venous invasion (2,3 vs 0,1) | 1.241 | 0.555–2.773 | 0.599 | |||
pT(4 vs 1,2,3) | 2.229 | 0.992–5.010 | 0.052 | |||
pN (2,3 vs 0,1) | 1.683 | 0.741–3.820 | 0.213 | |||
The number of positive lymph node (≥5 vs < 5) | 3.517 | 1.045–11.832 | 0.042 | 2.429 | 0.688–8.567 | 0.168 |
Histologic type (Differenciated vs Undifferenciated | 0.448 | 0.177–1.134 | 0.090 | |||
Approach (Laparo vs Open) | 1.513 | 0.625–3.662 | 0.359 | |||
Type of gastrectomy (TG vs DG/PG) | 1.525 | 0.674–3.450 | 0.311 | |||
Lymphadectomy (≥D2 vs < D2) | 0.501 | 0.221–1.136 | 0.098 | |||
Adjuvant chemotherapy (Present vs Absent) | 0.469 | 0.211–0.963 | 0.049 | 0.682 | 0.271–1.512 | 0.402 |
Postoperative complication (CD3 ≥vs < 3) | 1.984 | 0.589–6.689 | 0.269 | |||
CAR (≥0.064 vs < 0.064) | 0.577 | 0.229–1.458 | 0.245 | |||
NLR (≥2.273 vs < 2.273) | 1.186 | 0.526–2.675 | 0.681 | |||
PNI (≥49.8 vs < 49.8) | 2.760 | 1.217–8.522 | 0.046 | 3.321 | 1.116–10.856 | 0.047 |